Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

GLYCEROL MONOSTEARATE 40-55 CRS (2000 MG)

GLYCEROL MONOSTEARATE 40-55 CRS (2000 MG)

31566-31-1

DISCOVER
TRIACETIN - REFERENCE SPECTRUM (N/A)

TRIACETIN - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
GLYCERYL TRINITRATE SOLUTION CRS (0.5 ML)

GLYCERYL TRINITRATE SOLUTION CRS (0.5 ML)

55-63-0

DISCOVER
GLYCERYL TRINITRATE - REFERENCE SPECTRUM (N/A)

GLYCERYL TRINITRATE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
GLYCINE CRS (50 MG)

GLYCINE CRS (50 MG)

56-40-6

DISCOVER
Griseofulvin

Griseofulvin

126-07-8

DISCOVER
MONOAMMONIUM GLYCYRRHIZATE CRS (300 MG)

MONOAMMONIUM GLYCYRRHIZATE CRS (300 MG)

ND

DISCOVER
GONADORELIN CRS (5 MG)

GONADORELIN CRS (5 MG)

499785-55-6

DISCOVER
GRAMICIDIN CRS (250 MG)

GRAMICIDIN CRS (250 MG)

1405-97-6

DISCOVER
Griseofulvin

Griseofulvin

126-07-8

DISCOVER
GUAIFENESIN CRS (130 MG)

GUAIFENESIN CRS (130 MG)

93-14-1

DISCOVER
Glimepiride

Glimepiride

93479-97-1

DISCOVER